114 related articles for article (PubMed ID: 483241)
1. Separation of fibrinogen degradation products (FDP) by means of adsorption to insolubilized fibrinmonomer (FM-ag).
Heene DL; Matthias FR; Wegrzynowicz Z; Hocke G
Thromb Haemost; 1979 Jun; 41(4):677-86. PubMed ID: 483241
[TBL] [Abstract][Full Text] [Related]
2. Adsorption of fibrinogen and fragment D of fibrinogen onto the insolubilized alpha-chain of fibrin.
Matthias FR
Thromb Haemost; 1979 Jun; 41(4):687-90. PubMed ID: 483242
[TBL] [Abstract][Full Text] [Related]
3. [Preparation and separation of milligram amounts of canine fibrin(ogen) degradation products (fdp) X, Y, D and E].
Wolling H; Mischke R
Berl Munch Tierarztl Wochenschr; 1995 Nov; 108(11):421-6. PubMed ID: 8593135
[TBL] [Abstract][Full Text] [Related]
4. Biological behavior of higher molecular weight products of fibrinolysis.
Chang ML; Bang NU
J Lab Clin Med; 1977 Jul; 90(1):216-26. PubMed ID: 874368
[TBL] [Abstract][Full Text] [Related]
5. Isolation of fibrinogen from plasma by affinity chromatography on insolubilized fibrinogen (FG-ag) and insolubilized fibrinmonomer (FM-ag).
Matthias FR; Hocke G; Lasch HG
Thromb Res; 1975 Dec; 7(6):861-70. PubMed ID: 1198554
[No Abstract] [Full Text] [Related]
6. [Clinical significance of a new fibrinogen/fibrin degradation products(FDP) test using plasma samples for the diagnosis of fibrinogenolysis and fibrinolysis].
Imoto K; Yasumuro Y; Taki M; Suzuki N; Tanabe H; Ichikawa Y
Rinsho Byori; 2001 Mar; 49(3):283-9. PubMed ID: 11307330
[TBL] [Abstract][Full Text] [Related]
7. The effect of homologous thrombin and fibrinogen degradation products on fibrinogen synthesis in rabbits.
Kessler CM; Bell WR
J Lab Clin Med; 1979 May; 93(5):768-82. PubMed ID: 219123
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of cross-linked fibrin and fibrinogen degradation products with SDS-PAGE and immunoblot].
Okumura N; Kagiya H; Kumagai T; Kameko M; Tozuka M; Saito H; Katsuyama T; Kanai M
Rinsho Byori; 1990 Feb; 38(2):201-7. PubMed ID: 2329722
[TBL] [Abstract][Full Text] [Related]
9. Comparisons of hemagglutination inhibition, staphylococcal clumping, and latex agglutination tests for canine fibrinolytic degradation products.
Chen JP; Williams TK; Legendre AM
Am J Vet Res; 1981 Dec; 42(12):2049-52. PubMed ID: 7340573
[TBL] [Abstract][Full Text] [Related]
10. Proceedings: Determination of fibrinmonomer (FM) from plasma by affinity chromatography on insolubilized fibrinogen (FG-ag).
Matthias FR; Reinicke R; Heene DL; Lasch HG
Thromb Diath Haemorrh; 1975 Nov; 34(2):583-4. PubMed ID: 1198488
[No Abstract] [Full Text] [Related]
11. Binding properties on Sepharose insolubilized fibrinogen and fibrin, of various species of fibrinogen and fibrin solubilized in plasma.
Nilsen DW; Holm B; Brosstad F
Thromb Res; 1986 May; 42(4):449-59. PubMed ID: 3715811
[TBL] [Abstract][Full Text] [Related]
12. A simple rapid method for isolating soluble fibrin complexes from fibrinogen by treatment with thrombin and t-AMCHA.
Hayashi S; Yamada K
Thromb Haemost; 1980 Feb; 42(5):1388-97. PubMed ID: 6154323
[TBL] [Abstract][Full Text] [Related]
13. [Differentiation of fibrinolysis and fibrinogenolysis by analysis of FDP fragments].
Okumura N; Furuwatari C; Ishikawa S; Furihata K; Katsuyama T; Kanai M; Nakahata T; Saitoh H
Rinsho Byori; 1992 Jul; 40(7):789-94. PubMed ID: 1507499
[TBL] [Abstract][Full Text] [Related]
14. [Monoclonal antibodies against fibrinogen and fibrin and against their proteolytic degradation products].
Dyr JE; Cajthamlová H; Suttnar J
Cas Lek Cesk; 1990 Oct; 129(43):1349-51. PubMed ID: 2249231
[TBL] [Abstract][Full Text] [Related]
15. Fibrinogen-fibrin degradation products: hemagglutination inhibition immunoassay in plasma.
Chi DS; Chen JP
Tex Rep Biol Med; 1975; 33(4):493-508. PubMed ID: 133472
[TBL] [Abstract][Full Text] [Related]
16. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
Koga S
Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605
[TBL] [Abstract][Full Text] [Related]
17. Unreliability of current serum fibrin degradation product (FDP) assays.
Gaffney PJ; Perry MJ
Thromb Haemost; 1985 Jun; 53(3):301-2. PubMed ID: 3901388
[TBL] [Abstract][Full Text] [Related]
18. Quantitative assessment of soluble fibrin in plasma by affinity chromatography--a comparative study with desAA-fibrin, desAABB-fibrin and fibrinogen.
Thiel W; Delvos U; Müller-Berghaus G
Thromb Haemost; 1985 Aug; 54(2):533-8. PubMed ID: 4082091
[TBL] [Abstract][Full Text] [Related]
19. The monoclonal antibody that recognizes an epitope in the C-terminal region of the fibrinogen alpha-chain reacts with soluble fibrin and fibrin monomer generated by thrombin but not with those formed as plasmin degradation products.
Suzuki A; Ebinuma H; Matsuo M; Miyazaki O; Yago H
Thromb Res; 2007; 121(3):377-85. PubMed ID: 17561232
[TBL] [Abstract][Full Text] [Related]
20. Specific identification of urinary fibrinogen, fibrinogen degradation products, and cross-linked fibrin degradation products in renal diseases and after renal allotransplantation.
Scott WL; Francis CW; Knutson DW; Marder VJ
J Lab Clin Med; 1986 Jun; 107(6):534-43. PubMed ID: 3519810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
